The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role ...

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was ...

A group of 15 states have reached a tentative new deal that would require them to set aside hundreds of millions of dollars ...

Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...

This settlement is among the largest in recent years as lawsuits seek to hold companies accountable for the US opioid epidemic.